American journal of clinical oncology · 2026
The Role of Adjuvant Radiotherapy for the Prevention of Recurrent Hypertrophic Scars/Keloids: An American Radium Society (ARS) Appropriate Use Criteria (AUC).
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Russo Suzanne, Wee Corinne, Jean-Baptiste Samuel, Kirschner Austin N, Koneru Bobby, Kluwe Christien, Ling Diane C, Newman Neil, Pearlstein Kevin, Sharifzadeh Yasamin, Tendulkar Rahul, Dove Austin
Аннотация
OBJECTIVES: To summarize the evidence for adjuvant radiation therapy (RT) in the prevention of recurrent hypertrophic scars and keloids, including patient selection, optimal RT technique, and associated risks.
METHODS: This multi-specialty-led committee includes radiation oncology, plastic surgery, and dermatology physicians. Using the Population, Intervention, Comparator, Outcome, Timing, and Study Design (PICOTS) framework, evidence regarding treatment outcomes was assessed using Cochrane and PRISMA methodology. Eligible studies included prospective and retrospective studies published between January 1, 1980 and November 5, 2026, from the Ovid Medline database. Of the 165 articles identified using the search strategy, 87 were selected for inclusion as evidence, including 3 well-designed studies (phase II randomized and phase III), 23 moderately well-designed studies that account for most common biases (matched cohort and phase II studies), 50 studies with design limitations (retrospective reviews), 4 supplemental studies (not useful as primary evidence), and 7 meta-analyses. Eight additional studies were included to provide context and were not used to guide recommendations. Well-established RAND-UCLA consensus methodology (modified Delphi) was used to rate the appropriateness of the treatment options.
RESULTS: The results of this analysis demonstrate that RT is an effective and safe treatment strategy to reduce the risk of recurrent hypertrophic scars and keloids following surgery in appropriately selected patients.
CONCLUSIONS: This systematic review provides consensus guidelines for the use of adjuvant RT for the prevention of recurrent hypertrophic scars/keloids based on the available peer-reviewed evidence in the literature.
METHODS: This multi-specialty-led committee includes radiation oncology, plastic surgery, and dermatology physicians. Using the Population, Intervention, Comparator, Outcome, Timing, and Study Design (PICOTS) framework, evidence regarding treatment outcomes was assessed using Cochrane and PRISMA methodology. Eligible studies included prospective and retrospective studies published between January 1, 1980 and November 5, 2026, from the Ovid Medline database. Of the 165 articles identified using the search strategy, 87 were selected for inclusion as evidence, including 3 well-designed studies (phase II randomized and phase III), 23 moderately well-designed studies that account for most common biases (matched cohort and phase II studies), 50 studies with design limitations (retrospective reviews), 4 supplemental studies (not useful as primary evidence), and 7 meta-analyses. Eight additional studies were included to provide context and were not used to guide recommendations. Well-established RAND-UCLA consensus methodology (modified Delphi) was used to rate the appropriateness of the treatment options.
RESULTS: The results of this analysis demonstrate that RT is an effective and safe treatment strategy to reduce the risk of recurrent hypertrophic scars and keloids following surgery in appropriately selected patients.
CONCLUSIONS: This systematic review provides consensus guidelines for the use of adjuvant RT for the prevention of recurrent hypertrophic scars/keloids based on the available peer-reviewed evidence in the literature.